Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βUse of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeuticsβ.
Maryam Mooghali, Reshma Ramachandran, Joseph S. Ross, Joshua D. Wallach, Alissa K. Wong